Author:
Rubino Christopher M.,Polak Mark,Schröpf Sebastian,Münch Hans Georg,Smits Anne,Cossey Veerle,Tomasik Tomasz,Kwinta Przemko,Snariene Rima,Liubsys Arunas,Gardovska Dace,Hornik Chi Dang,Bosheva Miroslava,Ruehle Christine,Litherland Karine,Hamed Kamal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health
Reference20 articles.
1. New cephalosporins for the treatment of pneumonia in internal medicine wards.;Lupia;J Thorac Dis,2020
2. Ceftobiprole activity against bacteria from skin and skin structure infections in the United States from 2016 through 2018.;Flamm;Antimicrob Agents Chemother,2020
3. Ceftobiprole: drug evaluation and place in therapy.;Giacobbe;Expert Rev Anti Infect Ther,2019
4. Ceftobiprole compared with vancomycin plus aztreonam in the treatment of acute bacterial skin and skin structure infections: results of a phase 3, randomized, double-blind trial (TARGET) [published online ahead of print September 8, 2020].;Overcash;Clin Infect Dis
5. Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial.;Hamed;Future Microbiol,2020
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献